Symbol="BLUE"
AssetType="Common Stock"
Name="Bluebird bio Inc"
Description="bluebird bio, Inc., a biotechnology company, researches, develops and markets transformative gene therapies for serious genetic diseases and cancer. The company is headquartered in Cambridge, Massachusetts."
CIK="1293971"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="60 BINNEY STREET, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="373506000"
EBITDA="-133210000"
PERatio="None"
PEGRatio="0.32"
BookValue="2.715"
DividendPerShare="0"
DividendYield="0"
EPS="-1.41"
RevenuePerShareTTM="0.099"
ProfitMargin="0"
OperatingMarginTTM="-14.66"
ReturnOnAssetsTTM="-0.139"
ReturnOnEquityTTM="-0.409"
RevenueTTM="9404000"
GrossProfitTTM="-247244000"
DilutedEPSTTM="-1.41"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="3.536"
AnalystTargetPrice="7.36"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="125.49"
PriceToBookRatio="4.368"
EVToRevenue="161.97"
EVToEBITDA="-1.909"
Beta="0.947"
num_52WeekHigh="8.58"
num_52WeekLow="2.78"
num_50DayMovingAverage="3.565"
num_200DayMovingAverage="5.05"
SharesOutstanding="106412000"
DividendDate="None"
ExDividendDate="None"
symbol="BLUE"
open="3.40"
high="3.74"
low="3.39"
price="3.51"
volume="3494735.00"
latest_trading_day="2023-08-18"
previous_close="3.46"
change="0.05"
change_percent="1.4451%"
aroon_positive_momentum_days="33"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="33"
Volume_recent_avg="4636003"
Change_recent_avg="-0.02"
Delta_recent_avg="0.3"
Variance_recent_avg="0.15"
Change_ratio_recent_avg="-0.77"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="33"
Aroon_momentum_negative="67"
image_negative_thumbnail_id_1="1094"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0127.jpeg"
image_negative_thumbnail_id_2="98"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0078.jpeg"
image_neutral_thumbnail_id_1="542"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0057.jpeg"
image_neutral_thumbnail_id_2="532"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0067.jpeg"
image_positive_thumbnail_id_1="642"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0066.jpeg"
image_positive_thumbnail_id_2="705"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0003.jpeg"
image_professor_thumbnail_id_1="1180"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0014.jpeg"
image_professor_thumbnail_id_2="1169"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
